Hybrid closed-loop insulin delivery improves glycemic control and quality of life in adults with type 1 diabetes Tags Others Delivery devices Read more about Hybrid closed-loop insulin delivery improves glycemic control and quality of life in adults with type 1 diabetes
Automated Insulin Delivery Boosts Glycemic Control in Adults with Type 1 Diabetes Tags Others Delivery devices Read more about Automated Insulin Delivery Boosts Glycemic Control in Adults with Type 1 Diabetes
Automated Insulin Delivery Sustains Glycemic Control in 2–6-Year-Olds with T1D Tags Others Delivery devices Read more about Automated Insulin Delivery Sustains Glycemic Control in 2–6-Year-Olds with T1D
SGLT2 Inhibitors Outperform GLP-1RAs in Preserving Kidney Function in T2D Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Outperform GLP-1RAs in Preserving Kidney Function in T2D
Fixed-Dose Empagliflozin/Linagliptin Shows Superior HbA1c Reduction with Metformin Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about Fixed-Dose Empagliflozin/Linagliptin Shows Superior HbA1c Reduction with Metformin
Injection-Free Exenatide Device Shows Strong HbA1c Reductions in Poorly Controlled T2DM Read more about Injection-Free Exenatide Device Shows Strong HbA1c Reductions in Poorly Controlled T2DM
Efsitora Matches Degludec for Efficacy and Safety in Diabetes Tags Long acting Read more about Efsitora Matches Degludec for Efficacy and Safety in Diabetes
Automated Insulin Delivery Improves Glycemic Control in Type 2 Diabetes Regardless of C-Peptide Tags Others Delivery devices Read more about Automated Insulin Delivery Improves Glycemic Control in Type 2 Diabetes Regardless of C-Peptide
Meta-Analysis Confirms GLP-1 Therapy Improves Outcomes in Obese Patients With HFpEF Read more about Meta-Analysis Confirms GLP-1 Therapy Improves Outcomes in Obese Patients With HFpEF
The Heart of The Matter: Unveiling the SOUL Study Results Tags GLP-1 agonists Read more about The Heart of The Matter: Unveiling the SOUL Study Results